Eric J Ende Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Eric J Ende.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Eric J Ende. Eric J Ende is a Director in GENZYME CORP ($GENZ) and a in PROGENICS PHARMACEUTICALS INC ($PGNX) and a Director in PROGENICS PHARMACEUTICALS INC ($PGNX) and a Director in AVADEL PHARMACEUTICALS PLC ($AVDL) and a Director in Matinas BioPharma Holdings, Inc. ($MTNB).
Address: 500 KENDALL STREET CAMBRIDGE 02142 MA
Companies in which Eric J Ende is an Insider
AVADEL PHARMACEUTICALS PLC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Eric J Ende: Director
Holdings: 84,900 shares
Latest Transaction: Sep 18 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
GENZYME CORP
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Eric J Ende: Director
Holdings: 0 shares
Latest Transaction: Apr 06 2011
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Matinas BioPharma Holdings, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Eric J Ende: Director
Holdings: 115,292 shares
Current Value: $298,606
Latest Transaction: Jun 24 2020
$MTNB Market Capitalization: $149.76M
$MTNB Previous Close: $2.59
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
PROGENICS PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Eric J Ende: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 23 2020
$PGNX Market Capitalization: $671.09M
$PGNX Previous Close: $9.53
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Eric J Ende
Sentiment: All, AVDL, GENZ, MTNB, PGNX
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 18 2020 | AVDL | AVADEL PHARMACEUTI ... | Ende Eric J | Director | Buy | P | 5.79 | 17,000 | 98,376 | 84,900 | 67.9 K to 84.9 K (+25.04 %) |
| Aug 17 2020 | AVDL | AVADEL PHARMACEUTI ... | Ende Eric J | Director | Buy | P | 7.80 | 3,800 | 29,640 | 67,900 | 64.1 K to 67.9 K (+5.93 %) |
| Aug 17 2020 | AVDL | AVADEL PHARMACEUTI ... | Ende Eric J | Director | Buy | P | 7.74 | 1,200 | 9,288 | 64,100 | 62.9 K to 64.1 K (+1.91 %) |
| Aug 13 2020 | AVDL | AVADEL PHARMACEUTI ... | Ende Eric J | Director | Buy | P | 7.76 | 15,000 | 116,355 | 62,900 | 47.9 K to 62.9 K (+31.32 %) |
| Aug 11 2020 | AVDL | AVADEL PHARMACEUTI ... | Ende Eric J | Director | Option Exercise | A | 8.48 | 42,000 | 356,160 | 42,000 | |
| Jun 24 2020 | MTNB | Matinas BioPharma ... | Ende Eric J | Director | Buy | J | 0.00 | 3,600 | 0 | 115,292 | 111.7 K to 115.3 K (+3.22 %) |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Ende Eric J | Director | Option Exercise | D | 5.01 | 16,393 | 82,129 | 0 |